May 27 | 2024
Revised Financial Calendar Announcement
Read more
May 7 | 2024
2CUREX AB (PUBL) HAS DECIDED TO APPLY FOR A DELISTING OF ITS SHARES ON NASDAQ FIRST NORTH GROWTH MARKET IN STOCKHOLM – EXPECTED LAST DAY OF TRADING BY END OF JUNE
Read more
March 16 | 2024
2CUREX AB (PUBL) PROVIDES AN UPDATE ON ITS FINANCIAL POSITION AND CURRENT OPERATIONS
Read more
February 29 | 2024
KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)
Read more
February 29 | 2024
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)
Read more
February 22 | 2024
2CUREX PUBLISHES INTERIM REPORT FOR THE FOURTH QUARTER AND FULL YEAR OF 2023 AND FINANCIAL AND STRATEGIC OUTLOOK FOR 2024
Read more
February 12 | 2024
NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF 2CUREX AB (PUBL)
Read more
February 12 | 2024
KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)
Read more
January 4 | 2024
2cureX announces changes to the Board of Directors.
Read more
December 29 | 2023
2cureX announces changes to the management
Read more
December 6 | 2023
2cureX Receives Ethical Approval for Groundbreaking HIPEC Clinical Trial
Read more
November 23 | 2023
2cureX publishes interim report for the third quarter of 2023
Read more
November 14 | 2023
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN 2CUREX AB (PUBL)
Read more
November 14 | 2023
KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMAN I 2CUREX AB (PUBL)
Read more
November 10 | 2023
IndiTreat® Image Uploader gets IVD CE-Mark
Read more
October 30 | 2023
2cureX participated in “Knæk Cancer” panel discussion.
Read more
October 26 | 2023
Strategy update: Leapfrogging to the decentralization of IndiTreat® testing through full focus on automation
Read more
October 25 | 2023
KALLELSE TILL EXTRA BOLAGSSTÄMMA I 2CUREX AB (PUBL)
Read more